Publications | Lund University Publications

1 – 7 of 7

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Sonnevi%2C+Kristina%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Sonnevi%2C+Kristina%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2024
Mark Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Harrysson, Sara ; Eloranta, Sandra ; Ekberg, Sara ; Enblad, Gunilla ; Andersson, Per Ola ; Sonnevi, Kristina ; Ljungqvist, Maria ; Sander, Birgitta ; Jerkeman, Mats ^LU and Smedby, Karin E. (2024) In Leukemia and Lymphoma 65(4). p.534-537
- Contribution to journal › Letter
Mark MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma : the Nordic Lymphoma Group MCL7 VALERIA trial
Jerkeman, Mats ^LU ; Kolstad, Arne ; Hutchings, Martin ; Pasanen, Annika ; Meriranta, Leo ; Niemann, Carsten Utoft ; Jørgensen, Rasmus Rask Kragh ; El-Galaly, Tarec Christoffer ; Riise, Jon and Leppä, Sirpa , et al. (2024) In Blood Advances 8(2). p.407-415
- Contribution to journal › Article
Mark Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE) : a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Dreyling, Martin ; Doorduijn, Jeanette ; Giné, Eva ; Jerkeman, Mats ^LU ; Walewski, Jan ; Hutchings, Martin ; Mey, Ulrich ; Riise, Jon ; Trneny, Marek and Vergote, Vibeke , et al. (2024) In The Lancet 403(10441). p.2293-2306
- Contribution to journal › Article
2023
Mark Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma : The Swedish MCL complete Project
Jerkeman, Mats ^LU ; Ekberg, Sara ^LU ; Glimelius, Ingrid ; Albertsson-Lindblad, Alexandra ^LU ; Entrop, Joshua P. ; Ellin, Fredrik ^LU ; Sonnevi, Kristina ; Lewerin, Catharina ; Brandefors, Lena and Smedby, Karin E. (2023) In HemaSphere 7(8). p.928-928
- Contribution to journal › Article
2022
Mark Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line—A population-based study of 736 patients
Harrysson, Sara ; Eloranta, Sandra ; Ekberg, Sara ^LU ; Enblad, Gunilla ; El-Galaly, Tarec C. ; Sander, Birgitta ; Sonnevi, Kristina ; Andersson, Per Ola ; Jerkeman, Mats ^LU and Smedby, Karin E. (2022) In British Journal of Haematology 198(2). p.267-277
- Contribution to journal › Article
2021
Mark Detailed Long-Term Follow-Up of Patients Who Relapsed after the Nordic Mantle Cell Lymphoma Trials : MCL2 and MCL3
Eskelund, Christian Winther ; Dimopoulos, Kostas ; Kolstad, Arne ; Glimelius, Ingrid ; Räty, Riikka ; Gjerdrum, Lise Mette Rahbek ; Sonnevi, Kristina ; Josefsson, Pär ; Nilsson-Ehle, Herman and Bentzen, Hans H.N. , et al. (2021) In HemaSphere 5(1).
- Contribution to journal › Article
2016
Mark Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma : a Swedish Lymphoma Registry study
Melén, Christopher M. ; Enblad, Gunilla ; Sonnevi, Kristina ; Junlén, Henna Riikka ; Smedby, Karin E. ; Jerkeman, Mats ^LU and Wahlin, Björn Engelbrekt (2016) In British Journal of Haematology 175(4). p.614-622
- Contribution to journal › Article

your query:: Remove author: Sonnevi, Kristina